FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170657268> ?p ?o ?g. }

• W3170657268 endingPage "73" @default.
• W3170657268 startingPage "68" @default.
• W3170657268 abstract "To estimate the incidence of psoriatic arthritis (PsA) in patients with psoriasis who had received a continuous treatment with biological disease-modifying antirheumatic drugs (bDMARDs) compared with phototherapy.A retrospective non-randomised study involving patients with moderate-to-severe plaque psoriasis, who were prescribed at least 5 years of bDMARDs or at least three narrow-band ultraviolet light B (nb-UVB) phototherapy courses, and did not have a diagnosis of PsA at enrolment. Development of PsA in each patient was assessed by a rheumatologist according to the Classification for Psoriatic Arthritis criteria. The annual and cumulative incidence rate of PsA was estimated by using an event per person-years analysis. Cox proportional hazards models were undertaken to assess the hazard risk (HR) of PsA after adjustment for confounders.A total of 464 psoriatic patients (bDMARDs, n=234 and nb-UVB, n=230) were followed between January 2012 and September 2020 (corresponding to 1584 and 1478 person year of follow-up for the two groups, respectively). The annual incidence rate of PsA was 1.20 cases (95% CI 0.77 to 1.89) versus 2.17 cases (95% CI 1.53 to 3.06) per 100 patients/year in the bDMARDs versus phototherapy group, respectively (HR 0.29, 0.12-0.70; p=0.006). The variables independently associated with higher risk of PsA were older age (adjusted HR 1.04, 1.02-1.07), nail psoriasis (adjusted HR 3.15, 1.63-6.06) and psoriasis duration >10 years (adjusted HR 2.02, 1.09-3.76); notably, bDMARDs treatment was associated with a lower risk of incident PsA (adjusted HR 0.27, 0.11-0.66).bDMARDs treatment may delay or reduce the risk of incident PsA in patients with moderate-to-severe chronic plaque psoriasis." @default.
• W3170657268 created "2021-06-22" @default.
• W3170657268 creator A5004257322 @default.
• W3170657268 creator A5016818733 @default.
• W3170657268 creator A5057958762 @default.
• W3170657268 creator A5071075382 @default.
• W3170657268 creator A5087192032 @default.
• W3170657268 date "2021-06-18" @default.
• W3170657268 modified "2023-09-30" @default.
• W3170657268 title "Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis" @default.
• W3170657268 cites W2007386671 @default.
• W3170657268 cites W2032029227 @default.
• W3170657268 cites W2034654881 @default.
• W3170657268 cites W2043183494 @default.
• W3170657268 cites W2048020246 @default.
• W3170657268 cites W2056840860 @default.
• W3170657268 cites W2061412013 @default.
• W3170657268 cites W2083180635 @default.
• W3170657268 cites W2096261848 @default.
• W3170657268 cites W2099452946 @default.
• W3170657268 cites W2101251179 @default.
• W3170657268 cites W2109041707 @default.
• W3170657268 cites W2120161439 @default.
• W3170657268 cites W2141609479 @default.
• W3170657268 cites W2147334477 @default.
• W3170657268 cites W2150785318 @default.
• W3170657268 cites W2152653766 @default.
• W3170657268 cites W2153652405 @default.
• W3170657268 cites W2331679758 @default.
• W3170657268 cites W2539719631 @default.
• W3170657268 cites W2591844407 @default.
• W3170657268 cites W2762831095 @default.
• W3170657268 cites W2789999450 @default.
• W3170657268 cites W2806678383 @default.
• W3170657268 cites W2890308768 @default.
• W3170657268 cites W2912335857 @default.
• W3170657268 cites W2964703987 @default.
• W3170657268 cites W2965354284 @default.
• W3170657268 cites W4241915332 @default.
• W3170657268 doi "https://doi.org/10.1136/annrheumdis-2021-219961" @default.
• W3170657268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34144965" @default.
• W3170657268 hasPublicationYear "2021" @default.
• W3170657268 type Work @default.
• W3170657268 sameAs 3170657268 @default.
• W3170657268 citedByCount "42" @default.
• W3170657268 countsByYear W31706572682021 @default.
• W3170657268 countsByYear W31706572682022 @default.
• W3170657268 countsByYear W31706572682023 @default.
• W3170657268 crossrefType "journal-article" @default.
• W3170657268 hasAuthorship W3170657268A5004257322 @default.
• W3170657268 hasAuthorship W3170657268A5016818733 @default.
• W3170657268 hasAuthorship W3170657268A5057958762 @default.
• W3170657268 hasAuthorship W3170657268A5071075382 @default.
• W3170657268 hasAuthorship W3170657268A5087192032 @default.
• W3170657268 hasBestOaLocation W31706572681 @default.
• W3170657268 hasConcept C120665830 @default.
• W3170657268 hasConcept C121332964 @default.
• W3170657268 hasConcept C126322002 @default.
• W3170657268 hasConcept C141071460 @default.
• W3170657268 hasConcept C16005928 @default.
• W3170657268 hasConcept C167135981 @default.
• W3170657268 hasConcept C207103383 @default.
• W3170657268 hasConcept C2776260265 @default.
• W3170657268 hasConcept C2777077863 @default.
• W3170657268 hasConcept C2780564577 @default.
• W3170657268 hasConcept C44249647 @default.
• W3170657268 hasConcept C50382708 @default.
• W3170657268 hasConcept C61511704 @default.
• W3170657268 hasConcept C71924100 @default.
• W3170657268 hasConcept C72563966 @default.
• W3170657268 hasConcept C88879693 @default.
• W3170657268 hasConceptScore W3170657268C120665830 @default.
• W3170657268 hasConceptScore W3170657268C121332964 @default.
• W3170657268 hasConceptScore W3170657268C126322002 @default.
• W3170657268 hasConceptScore W3170657268C141071460 @default.
• W3170657268 hasConceptScore W3170657268C16005928 @default.
• W3170657268 hasConceptScore W3170657268C167135981 @default.
• W3170657268 hasConceptScore W3170657268C207103383 @default.
• W3170657268 hasConceptScore W3170657268C2776260265 @default.
• W3170657268 hasConceptScore W3170657268C2777077863 @default.
• W3170657268 hasConceptScore W3170657268C2780564577 @default.
• W3170657268 hasConceptScore W3170657268C44249647 @default.
• W3170657268 hasConceptScore W3170657268C50382708 @default.
• W3170657268 hasConceptScore W3170657268C61511704 @default.
• W3170657268 hasConceptScore W3170657268C71924100 @default.
• W3170657268 hasConceptScore W3170657268C72563966 @default.
• W3170657268 hasConceptScore W3170657268C88879693 @default.
• W3170657268 hasIssue "1" @default.
• W3170657268 hasLocation W31706572681 @default.
• W3170657268 hasLocation W31706572682 @default.
• W3170657268 hasOpenAccess W3170657268 @default.
• W3170657268 hasPrimaryLocation W31706572681 @default.
• W3170657268 hasRelatedWork W1566732118 @default.
• W3170657268 hasRelatedWork W1998912255 @default.
• W3170657268 hasRelatedWork W2114372554 @default.
• W3170657268 hasRelatedWork W2167905575 @default.
• W3170657268 hasRelatedWork W2304821432 @default.
• W3170657268 hasRelatedWork W2399108082 @default.

• next